Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 114

    1.

    Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.

    Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, Frankel AH, Tam FW, Dornhorst A, Frost G, Turner JJ.

    Diabetes Care. 2009 Jul;32(7):1137-42. Epub 2009 Feb 5.PMID: 19196889 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.

    Loipl J, Schmekal B, Biesenbach G.

    Ren Fail. 2005;27(3):305-8.PMID: 15957547 [PubMed - indexed for MEDLINE]Related articles

    3.

    Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.

    Hay LC, Wilmshurst EG, Fulcher G.

    Diabetes Technol Ther. 2003;5(1):19-26.PMID: 12725703 [PubMed - indexed for MEDLINE]Related articles

    4.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis.

    Abe M, Kikuchi F, Okada K, Kaizu K, Matsumoto K.

    Diabetes Res Clin Pract. 2008 Jun;80(3):432-8. Epub 2008 Mar 17.PMID: 18346811 [PubMed - indexed for MEDLINE]Related articles

    7.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The effect of continuous glucose monitoring in well-controlled type 1 diabetes.

    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.

    Diabetes Care. 2009 Aug;32(8):1378-83. Epub 2009 May 8.PMID: 19429875 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

    Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC.

    Diabetes. 2004 Apr;53(4):955-62.PMID: 15047610 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.

    Levy CJ, Kinsley BT, Bajaj M, Simonson DC.

    Diabetes Care. 1998 Aug;21(8):1330-8.PMID: 9702443 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.

    Wu MS, Yu CC, Wu CH, Haung JY, Leu ML, Huang CC.

    Perit Dial Int. 1999;19 Suppl 2:S179-83.PMID: 10406515 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.
    13.

    The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

    Monnier L, Colette C, Dunseath GJ, Owens DR.

    Diabetes Care. 2007 Feb;30(2):263-9.PMID: 17259492 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Adequacy of glycemic control in hemodialysis patients with diabetes.

    Tascona DJ, Morton AR, Toffelmire EB, Holland DC, Iliescu EA.

    Diabetes Care. 2006 Oct;29(10):2247-51.PMID: 17003301 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.

    Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S.

    Diabetes Care. 1998 Feb;21(2):283-90.PMID: 9539997 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.

    Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW.

    Perit Dial Int. 1995;15(2):129-33.PMID: 7612732 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data